Oncomap90 (Myeloid Panel)
Tailored for hematologic cancers, the Myeloid Neoplasms Focus Panel evaluates 92 genes involved in myeloid disorders such as acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs). It plays a crucial role in diagnosis, prognosis, and treatment selection by identifying mutations that can drive disease progression. The test accepts blood or bone marrow […]
Oncomap130 (Solid Tumor Panel)
The Solid Tumor Panel is a comprehensive test designed to detect genetic alterations in 50 genes that are frequently mutated across a wide range of solid tumors. This includes but is not limited to breast, colorectal, lung, and gastric cancers. By identifying these genetic mutations, the test helps oncologists make informed decisions about targeted therapies […]